‪Rocío Marisol Espinoza Chávez‬

Cited by

	All	Since 2019
Citations	65	65
h-index	3	3
i10-index	2	2

202020212022202320245 10 14 18 18

Public access

View all

1 article

0 articles

available

not available

Based on funding mandates

Co-authors

Luiz Carlos DiasFull Professor, University of Campinas - Unicamp (Universidade Estadual de Campinas)Verified email at unicamp.br
Adriano D. AndricopuloUniversidade de São PauloVerified email at ifsc.usp.br
Mariana Laureano de SouzaUniversity of California, San Diego - UCSDVerified email at alumni.usp.br
Leonardo L. G. Ferreira, Leonardo Lui...University of Sao PauloVerified email at ifsc.usp.br
Rafaela Salgado FerreiraBiochemistry and Immunology Department, Universidade Federal de Minas GeraisVerified email at icb.ufmg.br
Maria Laura BolognesiAlma Mater Studiorum - University of BolognaVerified email at unibo.it
Elisa UliassiUniversity of BolognaVerified email at unibo.it
Andrea IlariIBPM - CNRVerified email at uniroma1.it
Marilia ValliIFSC - USP University of Sao PauloVerified email at ifsc.usp.br
Aldo Sena de OliveiraProfessor do Magistério Superior (UFSC)Verified email at ufsc.br
celso de oliveira rezende júniorProfessor de Química, Universidade Federal de Uberlândia

Rocío Marisol Espinoza Chávez

PhD from State University of Campinas

Verified email at dac.unicamp.br - Homepage

Medicinal Chemistry Organic Synthesis Drug Discovery Infectious Diseases


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Discovery of potent, reversible, and competitive cruzain inhibitors with trypanocidal activity: a structure-based drug design approach ML de Souza, C de Oliveira Rezende Junior, RS Ferreira, ... Journal of Chemical Information and Modeling 60 (2), 1028-1041, 2019	44	2019
Chemoinformatics studies on a series of imidazoles as cruzain inhibitors AR Medeiros, LLG Ferreira, ML de Souza, C de Oliveira Rezende Junior, ... Biomolecules 11 (4), 579, 2021	11	2021
Targeted Protein Degradation for Infectious Diseases: From Basic Biology to Drug Discovery RM Espinoza-Chávez, A Salerno, A Liuzzi, A Ilari, A Milelli, E Uliassi, ... ACS bio & med Chem Au 3 (1), 32-45, 2022	9	2022
Structure–activity relationships of novel N-imidazoylpiperazines with potent anti-Trypanosoma cruzi activity RM Espinoza-Chávez, C Oliveira Rezende Júnior, ML de Souza, I Pauli, ... Future Medicinal Chemistry 16 (3), 253-269, 2024	1	2024
Chemoinformatics Studies on a Series of Imidazoles as Cruzain Inhibitors. Biomolecules 2021, 11, 579 AR Medeiros, LLG Ferreira, ML de Souza, C de Oliveira Rezende Junior, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021		2021
Carbamoyl Imidazoles As Potent, Reversible and Competitive Cruzain Inhibitors with in vitro and in vivo Trypanocidal Activity: A Structure-Based Drug Design … ML de Souza, COR Junior, RS Ferreira, RM Espinoza Chávez, L Ferreira, ... Reversible and Competitive Cruzain Inhibitors with in vitro and in vivo …, 2019		2019
Structure-Activity Relationships of Novel N-Imidazoylpiperazines with Potent Anti-Trypanosoma Cruzi Activity L Dias, RM Espinoza Chávez, COR Junior, ML de Souza, I Pauli, M Valli, ... Available at SSRN 4459415, 0

The system can't perform the operation now. Try again later.

Articles 1–7

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors